Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCD Probiotics is a Kansas City-based life sciences and industrial biotechnology company focused on probiotic- and postbiotic-based products for human health, agriculture, companion animal health, home care, and environmental applications. Founded in 1998 by Matt Wood, the company develops and manufactures live microbial consortia and fermented biochemical products rather than repackaging isolated probiotic strains. Its technology platform centers on patented Mother Cultures and microbial consortia that are licensed to partners and used to create finished products across multiple end markets. SCD Probiotics operates commercially and appears to function as a wholly owned subsidiary of Probiotic Holdings, which holds related manufacturing, R&D, and quality certifications. The business is better characterized as a commercial microbiome and bio-based products company than as a therapeutics developer with a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCD Probiotics.